Clinical Outcomes with Pemetrexed-Based Systemic Therapy in RET-Rearranged Lung Cancers

被引：0
|
作者：
Drilon, Alexander [1 ]
Bergagnini, Isabella [1 ]
Delasos, Lukas [1 ]
Sima, Camelia S. [1 ]
Smith, Roger [1 ]
Somwar, Romel [1 ]
Riely, Gregory J. [1 ]
Kris, Mark G. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
ROS1 ALK KRAS; RET; pemetrexed; rearrangement;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL03.05
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers
    Drilon, A.
    Bergagnini, I.
    Delasos, L.
    Sabari, J.
    Woo, K. M.
    Plodkowski, A.
    Wang, L.
    Hellmann, M. D.
    Joubert, P.
    Sima, C. S.
    Smith, R.
    Somwar, R.
    Rekhtman, N.
    Ladanyi, M.
    Riely, G. J.
    Kris, M. G.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1286 - 1291
  • [2] Targeted therapy outcomes in RET-rearranged lung cancers: drug or driver?
    Drilon, Alexander
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 5 - 6
  • [3] Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
    Offin, Michael
    Guo, Robin
    Wu, Stephanie L.
    Sabari, Joshua
    Land, Josiah D.
    Ni, Ai
    Montecalvo, Joseph
    Halpenny, Darragh F.
    Buie, Larry W.
    Pak, Terry
    Liu, Dazhi
    Riely, Gregory J.
    Hellmann, Matthew D.
    Benayed, Ryma
    Arcila, Maria
    Kris, Mark G.
    Rudin, Charles M.
    Li, Bob T.
    Ladanyi, Marc
    Rekhtman, Natasha
    Drilon, Alexander
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 8
  • [4] Decade in review: a new era for RET-rearranged lung cancers
    Choudhury, Noura J.
    Drilon, Alexander
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2571 - 2580
  • [5] RET-rearranged lung cancers: Immunophenotype and response to immunotherapy.
    Sabari, Joshua K.
    Offin, Michael David
    Wu, Stephanie L.
    Ni, Ai
    Halpenny, Darragh
    Montecalvo, Joseph
    Liu, Dazhi
    Pak, Terry K.
    Arbour, Kathryn Cecilia
    Lai, Wei-Chu Victoria
    Hellmann, Matthew David
    Riely, Gregory J.
    Kris, Mark G.
    Rudin, Charles M.
    Rekhtman, Natasha
    Li, Bob T.
    Land, Josiah David
    Drilon, Alexander E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
    Drilon, Alexander
    Lin, Jessica J.
    Filleron, Thomas
    Ni, Ai
    Milia, Julie
    Bergagnini, Isabella
    Hatzoglou, Vaios
    Velcheti, Vamsidhar
    Offin, Michael
    Li, Bob
    Carbone, David P.
    Besse, Benjamin
    Mok, Tony
    Awad, Mark M.
    Wolf, Jurgen
    Owen, Dwight
    Camidge, D. Ross
    Riely, Gregory J.
    Peled, Nir
    Kris, Mark G.
    Mazieres, Julien
    Gainor, Justin F.
    Gautschi, Oliver
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : 1595 - 1601
  • [7] Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC
    Tan, Aaron C.
    Seet, Amanda O. L.
    Lai, Gillianne G. Y.
    Lim, Tse Hui
    Lim, Alvin S. T.
    Tan, Gek San
    Takano, Angela
    Tai, David W. M.
    Tan, Tira J. Y.
    Lam, Justina Y. C.
    Ng, Matthew C. H.
    Tan, Wan Ling
    Ang, Mei-Kim
    Kanesvaran, Ravindran
    Ng, Quan Sing
    Jain, Amit
    Rajasekaran, Tanujaa
    Lim, Wan-Teck
    Tan, Eng-Huat
    Lim, Tony Kiat Hon
    Tan, Daniel S. W.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (12) : 1928 - 1934
  • [8] Baseline frequency of brain metastases and outcomes with multikinase inhibitor therapy in patients with RET-rearranged lung cancers.
    Drilon, Alexander E.
    Filleron, Thomas
    Bergagnini, Isabella
    Milia, Julie
    Hatzoglou, Vaios
    Velcheti, Vamsidhar
    Besse, Benjamin
    Mok, Tony
    Awad, Mark M.
    Wolf, Juergen
    Carbone, David P.
    Camidge, D. Ross
    Riely, Gregory J.
    Peled, Nir
    Mazieres, Julien
    Kris, Mark G.
    Gautschi, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers
    Hubbeling, H. G.
    Choudhury, N.
    Falcon, C.
    Rusch, V. W.
    Park, B.
    Ziv, E.
    Shaverdian, N.
    Gelblum, D.
    Shepherd, A. F.
    Simone, C. B., II
    Wu, A. J.
    Gomez, D. R.
    Drilon, A.
    Rimner, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E438 - E439
  • [10] Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers
    Hubbeling, Harper
    Choudhury, Noura
    Flynn, Jessica
    Zhang, Zhigang
    Falcon, Christina
    Rusch, Valerie W.
    Park, Bernard J.
    Ziv, Etay
    Shaverdian, Narek
    Gelblum, Daphna Y.
    Shepherd, Annemarie F.
    Simone, Charles B., II
    Wu, Abraham J.
    Gomez, Daniel R.
    Drilon, Alexander
    Rimner, Andreas
    JCO PRECISION ONCOLOGY, 2022, 6
12345